Rationale for Type of Resection in Cancer of the Esophagus and Gastroesophageal Junction
Despite new insights into its molecular basis and various treatment options evaluated in numerous trials, therapy of esophageal cancer remains a challenge. In the past, surgery was the only treatment option. A patient qualified for surgery when he presented in stable condition and when the tumor was believed to be resectable. Today a vast number of treatment strategies, including induction chemotherapy, radiochemotherapy with or without combination with surgery, administered in an adjuvant or a neoadjuvant setting, are added to the traditional therapy of surgery alone. Even the question, whether surgery after effective chemoradiation does have any impact on prognosis at all or is no more than a “big biopsy” is discussed today. There is increasing evidence that patients may benefit from induction chemotherapy.
KeywordsEsophageal Cancer Esophageal Carcinoma Gastroesophageal Junction Oesophageal Cancer Celiac Trunk
Unable to display preview. Download preview PDF.
- 2.Bedenne L, Michel P, Bouche O et al (2002) Randomized phase III trial in locally advanced esophageal cancer: radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102). Am Soc Clin Oncol Proc, p 519 (abstract)Google Scholar
- 15.Fujita H, Kakegawa T, Yamana H, Shima I, Toh Y, Tomita Y, Fujii T, Yamasaki K, Higaki K, Noake T et al (1995) Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg 222:654–662PubMedCrossRefGoogle Scholar
- 18.Lerut T, Nafteux P, Moons J, Coosemans W, Decker G, De Leyn P, Van Raemdonck D, Ectors N (2004) Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 240:962–974PubMedCrossRefGoogle Scholar
- 28.Doggett RLS, Guernsey JM, Bagshaw MA (1970) Combined radiation and surgical treatment of carcinoma of the thoracic esophagus. Front Radiat Ther Oncol 5:147–154Google Scholar
- 30.Siewert JR, Hölscher AH (eds) Diseases of the Esophagus. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
- 31.Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, Stalmeier PF, ten Kate FJ, van Dekken H, Obertop H, Tilanus HW, van Lanschot JJ (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347(21):1662–1669PubMedCrossRefGoogle Scholar
- 33.Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, Passlick B, Broelsch CE, Pantel K (1997) Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. New Engl J Med 337?1188–1194PubMedCrossRefGoogle Scholar